Cargando…

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC). However, the development of drug resistance is common. By using genome-wide CRISPR/Cas9 library screening, we identify phosphoglycerate dehydrogenase (PHGDH), the first committed enzyme in the serine synthesis pathway (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Lai, Lee, Derek, Law, Cheuk-Ting, Zhang, Misty Shuo, Shen, Jialing, Chin, Don Wai-Ching, Zhang, Allen, Tsang, Felice Ho-Ching, Wong, Ceci Lok-Sze, Ng, Irene Oi-Lin, Wong, Carmen Chak-Lui, Wong, Chun-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794322/ https://www.ncbi.nlm.nih.gov/pubmed/31615983 http://dx.doi.org/10.1038/s41467-019-12606-7

Ejemplares similares

Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer
por: Cheng, Carol Lai-Hung, et al.
Publicado: (2021)

In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma
por: Wong, Lok-Sze, et al.
Publicado: (2022)

ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC
por: Wang, Huihui, et al.
Publicado: (2023)

The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
por: Chow, Ariel Ka-Man, et al.
Publicado: (2013)

MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis
por: Wong, Chun-Ming, et al.
Publicado: (2015)

Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)

Mechanism of sorafenib resistance associated with ferroptosis in HCC
por: Guo, Lingling, et al.
Publicado: (2023)

Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
por: Unterlass, Judith E., et al.
Publicado: (2016)

Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer
por: Tse, Aki Pui-Wah, et al.
Publicado: (2018)

GHR knockdown enhances the sensitivity of HCC cells to sorafenib
por: Gao, Shuang, et al.
Publicado: (2020)

Changing TACTICS in intermediate HCC: TACE plus sorafenib
por: Radu, Pompilia, et al.
Publicado: (2020)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
por: Lai, Hong-Yue, et al.
Publicado: (2021)

Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2014)

Increased PHGDH expression promotes aberrant melanin accumulation
por: Mattaini, Katherine R., et al.
Publicado: (2019)

Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer
por: Jia, Xiao-qin, et al.
Publicado: (2016)

PHGDH as a mechanism for resistance in metabolically-driven cancers
por: Rathore, Richa, et al.
Publicado: (2020)

Multi-omics Analysis of the Role of PHGDH in Colon Cancer
por: Dai, Zhihui, et al.
Publicado: (2023)

Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2008)

Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment
por: Yang, Chunxue, et al.
Publicado: (2022)

Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD‐L1
por: Chui, Noreen Nog‐Qin, et al.
Publicado: (2021)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
por: Leung, Zoe, et al.
Publicado: (2019)

PHGDH supports liver ceramide synthesis and sustains lipid homeostasis
por: Kang, Yun Pyo, et al.
Publicado: (2020)

Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma
por: Kai, Alan Ka‐Lun, et al.
Publicado: (2016)

Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
por: Chiu, David Kung-Chun, et al.
Publicado: (2017)

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
por: Palmer, D H, et al.
Publicado: (2013)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells
por: Shrestha, Ritu, et al.
Publicado: (2021)

Correction: EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2014)

EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2013)

Effectiveness of Using Mobile Technology to Improve Cognitive and Social Skills Among Individuals With Autism Spectrum Disorder: Systematic Literature Review
por: Leung, Phil Wai Shun, et al.
Publicado: (2021)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

Down regulating PHGDH affects the lactate production of sertoli cells in varicocele
por: Guo, Wen-bin, et al.
Publicado: (2020)

Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function
por: Xu, Hanyu, et al.
Publicado: (2021)

A PHGDH inhibitor reveals coordination of serine synthesis and 1-carbon unit fate
por: Pacold, Michael E., et al.
Publicado: (2016)

Phosphorylation of Nucleophosmin at Threonine 234/237 is associated with HCC metastasis
por: Ha Ching, Rachel Hiu, et al.
Publicado: (2015)

Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC
por: Hajighasemlou, Saieh, et al.
Publicado: (2020)

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
por: Fornari, Francesca, et al.
Publicado: (2021)

Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer
por: Zhang, Misty Shuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1535qlhtb1oevkojflj1o0e1uf